AGIO
Price
$28.73
Change
+$0.93 (+3.35%)
Updated
Jan 14 closing price
Capitalization
1.68B
28 days until earnings call
Intraday BUY SELL Signals
OLMA
Price
$28.77
Change
+$0.88 (+3.16%)
Updated
Jan 14 closing price
Capitalization
2.31B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AGIO vs OLMA

Header iconAGIO vs OLMA Comparison
Open Charts AGIO vs OLMABanner chart's image
Agios Pharmaceuticals
Price$28.73
Change+$0.93 (+3.35%)
Volume$769.2K
Capitalization1.68B
Olema Pharmaceuticals
Price$28.77
Change+$0.88 (+3.16%)
Volume$1.33M
Capitalization2.31B
AGIO vs OLMA Comparison Chart in %
AGIO
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AGIO vs. OLMA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and OLMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AGIO: $28.73 vs. OLMA: $28.77)
Brand notoriety: AGIO and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 40% vs. OLMA: 28%
Market capitalization -- AGIO: $1.68B vs. OLMA: $2.31B
AGIO [@Biotechnology] is valued at $1.68B. OLMA’s [@Biotechnology] market capitalization is $2.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 0 green, 5 red.
According to our system of comparison, OLMA is a better buy in the long-term than AGIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 7 TA indicator(s) are bullish while OLMA’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 7 bullish, 2 bearish.
  • OLMA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than OLMA.

Price Growth

AGIO (@Biotechnology) experienced а +0.67% price change this week, while OLMA (@Biotechnology) price change was +6.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

AGIO is expected to report earnings on Feb 12, 2026.

OLMA is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($2.31B) has a higher market cap than AGIO($1.68B). OLMA YTD gains are higher at: 15.080 vs. AGIO (5.547). OLMA has higher annual earnings (EBITDA): -164.96M vs. AGIO (-470.31M). AGIO has more cash in the bank: 953M vs. OLMA (329M). OLMA has less debt than AGIO: OLMA (4.48M) vs AGIO (44.5M). AGIO has higher revenues than OLMA: AGIO (44.8M) vs OLMA (0).
AGIOOLMAAGIO / OLMA
Capitalization1.68B2.31B73%
EBITDA-470.31M-164.96M285%
Gain YTD5.54715.08037%
P/E Ratio3.82N/A-
Revenue44.8M0-
Total Cash953M329M290%
Total Debt44.5M4.48M994%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOOLMA
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICELX49.290.26
+0.53%
NYLI Epoch International Choice Inv Cl
ADKSX34.130.14
+0.41%
Adirondack Small Cap
PQIRX26.42N/A
N/A
Victory Pioneer Equity Income R
PGELX27.72-0.06
-0.22%
George Putnam Balanced R5
HGIFX54.84-0.32
-0.58%
Hartford Core Equity F

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with TPST. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+3.35%
TPST - AGIO
56%
Loosely correlated
-6.59%
AXON - AGIO
45%
Loosely correlated
-1.92%
NRIX - AGIO
45%
Loosely correlated
+0.58%
RAPT - AGIO
41%
Loosely correlated
+1.97%
VCYT - AGIO
38%
Loosely correlated
-1.39%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with ORMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+3.16%
ORMP - OLMA
37%
Loosely correlated
+7.37%
VERA - OLMA
36%
Loosely correlated
-1.41%
VNDA - OLMA
35%
Loosely correlated
+3.49%
AGIO - OLMA
35%
Loosely correlated
+3.35%
NUVL - OLMA
34%
Loosely correlated
+6.59%
More